Carcinoma, Bronchogenic  >>  Tookad (padeliporfin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tookad (padeliporfin) / ImPact Biotech
NCT00974662 / 2009-011895-31: Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer

Terminated
2
3
Europe
WST11, WST11-mediated VTP
Steba Biotech S.A.
Non-Small Cell Lung Cancer
11/10
12/11

Download Options